Search results

Diabetes is one of the life-threatening chronic diseases, which is already affecting 422m people globally based on (World Health Organization) WHO report as at 2018. This costs individuals, government and groups a whole lot; right from its diagnosis stage to the treatment stage. The reason for this cost, among others, is that it is a long-term treatment disease. This disease is likely to continue to affect more people because of its long asymptotic phase, which makes its early detection not feasible.

In this study, the authors have presented machine learning models with feature selection, which can detect diabetes disease at its early stage. Also, the models presented are not costly and available to everyone, including those in the remote areas.

The study result shows that feature selection helps in getting better model, as it prevents overfitting and removes redundant data. Hence, the study result when compared with previous research shows the better result has been achieved, after it was evaluated based on metrics such as F-measure, Precision-Recall curve and Receiver Operating Characteristic Area Under Curve. This discovery has the potential to impact on clinical practice, when health workers aim at diagnosing diabetes disease at its early stage.

This study has not been published anywhere else.

Diagnosing brain tumors is a process that demands a significant amount of time and is heavily dependent on the proficiency and accumulated knowledge of radiologists. Over the traditional methods, deep learning approaches have gained popularity in automating the diagnosis of brain tumors, offering the potential for more accurate and efficient results. Notably, attention-based models have emerged as an advanced, dynamically refining and amplifying model feature to further elevate diagnostic capabilities. However, the specific impact of using channel, spatial or combined attention methods of the convolutional block attention module (CBAM) for brain tumor classification has not been fully investigated.

To selectively emphasize relevant features while suppressing noise, ResNet50 coupled with the CBAM (ResNet50-CBAM) was used for the classification of brain tumors in this research.

The ResNet50-CBAM outperformed existing deep learning classification methods like convolutional neural network (CNN), ResNet-CBAM achieved a superior performance of 99.43%, 99.01%, 98.7% and 99.25% in accuracy, recall, precision and AUC, respectively, when compared to the existing classification methods using the same dataset.

Since ResNet-CBAM fusion can capture the spatial context while enhancing feature representation, it can be integrated into the brain classification software platforms for physicians toward enhanced clinical decision-making and improved brain tumor classification.

This research has not been published anywhere else.